281 related articles for article (PubMed ID: 19492312)
1. An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.
Qi S; Weuts I; De Cort S; Stokbroekx S; Leemans R; Reading M; Belton P; Craig DQ
J Pharm Sci; 2010 Jan; 99(1):196-208. PubMed ID: 19492312
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol.
Qi S; Avalle P; Saklatvala R; Craig DQ
Eur J Pharm Biopharm; 2008 May; 69(1):364-71. PubMed ID: 18036792
[TBL] [Abstract][Full Text] [Related]
3. The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin.
Priemel PA; Grohganz H; Gordon KC; Rades T; Strachan CJ
Eur J Pharm Biopharm; 2012 Sep; 82(1):187-93. PubMed ID: 22683936
[TBL] [Abstract][Full Text] [Related]
4. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
Karmwar P; Boetker JP; Graeser KA; Strachan CJ; Rantanen J; Rades T
Eur J Pharm Sci; 2011 Oct; 44(3):341-50. PubMed ID: 21884789
[TBL] [Abstract][Full Text] [Related]
5. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.
Bhugra C; Shmeis R; Krill SL; Pikal MJ
Pharm Res; 2006 Oct; 23(10):2277-90. PubMed ID: 16933094
[TBL] [Abstract][Full Text] [Related]
6. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy.
Columbano A; Buckton G; Wikeley P
Int J Pharm; 2002 Apr; 237(1-2):171-8. PubMed ID: 11955815
[TBL] [Abstract][Full Text] [Related]
7. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
8. Quantifying crystallisation rates of amorphous pharmaceuticals with dynamic mechanical analysis (DMA).
Soutari N; Buanz AB; Gul MO; Tuleu C; Gaisford S
Int J Pharm; 2012 Feb; 423(2):335-40. PubMed ID: 22101291
[TBL] [Abstract][Full Text] [Related]
9. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
10. Differential scanning calorimetry predicts the critical quality attributes of amorphous glibenclamide.
Mah PT; Laaksonen T; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Sci; 2015 Dec; 80():74-81. PubMed ID: 26296864
[TBL] [Abstract][Full Text] [Related]
11. Phase transformations undergone by Triton X-100 probed by differential scanning calorimetry and dielectric relaxation spectroscopy.
Merino EG; Rodrigues C; Viciosa MT; Melo C; Sotomayor J; Dionísio M; Correia NT
J Phys Chem B; 2011 Nov; 115(43):12336-47. PubMed ID: 21928821
[TBL] [Abstract][Full Text] [Related]
12. Determining the critical relative humidity for moisture-induced phase transitions.
Burnett DJ; Thielmann F; Booth J
Int J Pharm; 2004 Dec; 287(1-2):123-33. PubMed ID: 15541919
[TBL] [Abstract][Full Text] [Related]
13. New solid modifications of nateglinide.
Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Lanfranconi S; Marini A
J Pharm Biomed Anal; 2010 Apr; 51(5):1054-9. PubMed ID: 20022441
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of blends of paracetamol and citric acid.
Hoppu P; Jouppila K; Rantanen J; Schantz S; Juppo AM
J Pharm Pharmacol; 2007 Mar; 59(3):373-81. PubMed ID: 17331340
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
[TBL] [Abstract][Full Text] [Related]
16. Use of ramping and equilibrium water vapor sorption methods to determine the critical relative humidity at which the glassy to rubbery transition occurs in polydextrose.
Li QE; Schmidt SJ
J Food Sci; 2011; 76(1):E149-57. PubMed ID: 21535666
[TBL] [Abstract][Full Text] [Related]
17. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
[TBL] [Abstract][Full Text] [Related]
18. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
19. Bulk, surface properties and water uptake mechanisms of salt/acid amorphous composite systems.
Bianco S; Tewes F; Tajber L; Caron V; Corrigan OI; Healy AM
Int J Pharm; 2013 Nov; 456(1):143-52. PubMed ID: 23948137
[TBL] [Abstract][Full Text] [Related]
20. An investigation into water interactions with amorphous and milled salbutamol sulphate: the development of predictive models for uptake and recrystallization.
Grisedale LC; Belton PS; Jamieson MJ; Barker SA; Craig DQ
Int J Pharm; 2012 Jan; 422(1-2):220-8. PubMed ID: 22100976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]